 | • レポートコード：MRC2203A149 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の細胞分離市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（消耗品、機器）分析、種類別（ヒト、動物）分析、用途別（研究所・機関、バイオテクノロジー・バイオ医薬品企業、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の細胞分離市場規模：製品別（消耗品、機器） ・世界の細胞分離市場規模：種類別（ヒト、動物） ・世界の細胞分離市場規模：用途別（研究所・機関、バイオテクノロジー・バイオ医薬品企業、その他） ・世界の細胞分離市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Becton Dickinson and Company、GE Healthcare、Merck KgaA、…） ・市場機会・将来傾向 |
The cell isolation/cell separation market studied was anticipated to grow with a CAGR of 17.2%, during the forecast period. Cell separation/Cell isolation technologies are generally used in the diagnosis of diseases, cellular research, and cellular therapies. The factors such as increasing incidence and prevalence of chronic diseases with an aging population, growing demand for biopharmaceuticals, technological advancement in cell isolation, and increasing stem cell research are driving cell isolation/cell separation market.
According to the World Health Organization (WHO), Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in the year 2018. Globally, about 1 in 6 deaths is due to cancer disease. Approximately 70% of deaths from cancer disease occur in low- and middle-income countries. Therefore with the increasing prevalence of chronic diseases and technological advancement and innovation in cell isolation are the key driving factors in the cell isolation market.
Key Market Trends
Human Cell Segment is Expected to Hold a Significant Market Share in the Cell Isolation Market
Human Cell therapy is a type of therapy in which live cells are injected into a patient with cell isolation/separation technique for the treatment of a number of disorders. For example, T-cells are injected into a patient for the treatment of cancer as they are capable of fighting cancer cells during the immunotherapy treatment.
According to the World Health Organization (WHO), Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in the year 2018. Globally, about 1 in 6 deaths is due to cancer disease. Approximately 70% of deaths from cancer disease occur in low- and middle-income countries.
Therefore the increasing prevalence of chronic diseases and technological advancement and innovation in cell isolation are the key driving factors in the human cell segment.
North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period
North America is expected to hold a dominating position in the global cell isolation market due to well-established infrastructure for life science research along with a highly organized regulatory structure for the companies focusing on the development of novel treatments.
According to the National Cancer Institute, in the year 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people will die from the disease. Moreover, increasing expenditure on research and development by the private and public players will also augment the growth of this market.
Competitive Landscape
The cell isolation market is fragmented competitive and consists of several market participants. In terms of market share, few of the major players are currently dominating the market. Some players are adopting numerous strategies including acquisitions and collaborations to sustain market competition. Some of the companies which are currently domianting the market are Becton Dickinson and Company, GE Healthcare, Merck KgaA, Thermo Fisher Scientific, Bio-Rad Laboratories Inc, Terumo BCT, PluriSelect Life Science UG & Co. KG, MiltenyiBiotec, Beckman Coulter, Inc and STEMCELL Technologies Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases
4.2.2 Technological Advancement and Innovation in Cell Isolation
4.3 Market Restraints
4.3.1 Strict Regulations and Compliances for Cell Separation
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Consumables
5.1.1.1 Reagents & kits
5.1.1.2 Beads
5.1.1.3 Disposables
5.1.2 Instruments
5.1.2.1 Centrifuges
5.1.2.2 Flow cytometers
5.1.2.3 Filtration systems
5.1.2.4 Magnetic-activated cell separator systems
5.2 By Type
5.2.1 Human
5.2.2 Animal
5.3 By Application
5.3.1 Research Laboratories and Institutes
5.3.2 Biotechnology and Biopharmaceutical Companies
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton Dickinson and Company
6.1.2 GE Healthcare
6.1.3 Merck KgaA
6.1.4 Thermo Fisher Scientific
6.1.5 Bio-Rad Laboratories Inc
6.1.6 Terumo BCT
6.1.7 PluriSelect Life Science UG & Co. KG
6.1.8 MiltenyiBiotec
6.1.9 Beckman Coulter, Inc
6.1.10 STEMCELL Technologies Inc
7 MARKET OPPORTUNITIES AND FUTURE TRENDS